Roundtable talk focuses on improving HIV treatment access among vulnerable populations

Research at International HIV Treatment as Prevention Workshop highlights need to target key affected populations and address stigma


International leaders discuss the importance of new HIV treatment targets during the roundtable discussion at the opening of the International HIV Treatment as Prevention Workshop in Vancouver.

Hundreds of leading HIV scientists from around the world gathered in Vancouver this April to share the results of their latest research on HIV prevention at the 4th International HIV Treatment as Prevention Workshop.

Previous workshops have focused on whether expanding treatment access is the most effective strategy to fight the global epidemic of HIV and AIDS. At this year’s workshop, researchers were ready to discuss best approaches to implementing the strategy.

“Finally there is a consensus emerging that the science clearly demonstrates treatment is highly effective in stopping transmission in all contexts,” said Dr. Julio Montaner, director of the BC Centre for Excellence in HIV/AIDS (BC-CfE) and co-chair of the workshop. He argued for being more efficient by identifying who should be treated and when.

Specifically, vulnerable populations such as women, children, and men who have sex with men remain at-risk as a result of ongoing discrimination in many countries, limiting their access to life-saving treatment and care.

“Progress is very uneven,” said Dr. Luiz Loures, UNAIDS Deputy Executive Director. “The likelihood of access to treatment and prevention is much lower for certain key minorities such as LGBTI [lesbian, gay, bisexual, transgender, and intersex], prisoners, migrants, sex workers, persons who injects drugs, and young women in Sub-Saharan Africa today.”

Dr. Loures’ remarks were made during the opening session of the four-day workshop. The roundtable session gathered high-level delegates from across the globe with the intention of bringing together key national decision-makers and pivotal international partners to explore the importance of new HIV treatment strategies and targets.

The session, co-hosted by UNAIDS and the BC-CfE, comprised representatives from the three key groups influencing HIV strategy—politicians, scientists and community—and set the agenda for the rest of the workshop.

“We should be setting one goal, and one goal only: to end HIV as an epidemic,” said Dr. Mark Dybul, Executive Director of the Global Fund to Fight AIDS, Tuberculosis & Malaria. During his presentation, he spoke of the need to move away from generalized targets and instead focus HIV treatment and prevention efforts on key affected populations, the people most marginalized and made vulnerable as a result of societal determinants.

“We have to bring the epidemic under control within all of these affected populations,” Dr. Dybul said. “If we don’t, we will continue to leave people behind.”

Evidence presented at the workshop supported his argument. In Vietnam, for example, hot spotting—targeting those regions where the HIV epidemic is most concentrated—has proven effective in reducing HIV transmission, according to research presented by Dr. Brian Williams of the South African Centre for Epidemiological Modelling and Analysis (SACEMA). Efficiency, he said, dictates HIV testing where the prevalence is highest.

Promising research results suggested the end of AIDS is within reach. However, conference delegates were cautioned that success is not guaranteed, and ending AIDS will demand new ways of operating. Eliminating stigma and discrimination—and engaging and giving voice to communities—may be the only way forward to ending the HIV epidemic.

Reaching those who are being missed by current treatment efforts is in opposition to punitive legal and policy frameworks that deter individuals from seeking the services they need. During the opening session, it was noted that 77 countries criminalize same-sex relationships, and that children are substantially less likely than adults to receive HIV treatment when they are eligible.

“We need to understand and act on local epidemics,” said Dr. Loures. “We need to understand how they operate and understand how we can respond to them. This is much easier to do if you are bringing services closer to communities and to people.”

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)